Quoin Pharmaceuticals Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	2.4	2.86	7.48	0.32	5.59	5.5	4.24	1.94	1.21	0.65
Short-Term Investments	8.29	9.99	0	0	0	0	4.32	7.61	2.42	3.47
Cash & Cash Equivalents	10.69	12.85	7.48	0.32	5.59	5.5	8.56	9.55	3.62	4.13
Cash Growth	-16.79%	71.77%	2210.70%	-94.21%	1.67%	-35.78%	-10.35%	163.46%	-12.24%	-
Receivables	0	0	0	0	0.17	0.25	0.25	0.45	0.13	0.05
Other Current Assets	0.59	0.52	0.72	0.14	-0.03	0	0	0	0	0
Total Current Assets	11.29	13.37	8.2	0.47	5.73	5.75	8.81	10	3.75	4.18
Property, Plant & Equipment	0	0	0	0	0.72	0.48	0.41	0.42	0.37	0.07
Long-Term Investments	0	0	0	0	0.1	0.1	0.09	0.04	0.01	0.01
Goodwill and Intangibles	0.58	0.7	0.81	0.91	0	0	0	0	0	0
Other Long-Term Assets	0.3	0.38	0.35	0	0.03	0.04	0.05	-0	-0	0
Total Long-Term Assets	0.88	1.09	1.16	0.91	0.85	0.62	0.56	0.47	0.37	0.08
Total Assets	12.17	14.46	9.36	1.38	6.58	6.37	9.37	10.47	4.12	4.26
Accounts Payable	0.53	0.61	0.92	4.89	1	1.51	1.27	1.08	0.88	0.26
Current Debt	0	0	0	1.21	0.12	0	0	0	0	0
Other Current Liabilities	3.05	2.92	3.65	1.88	0	0	0	0	0	0
Total Current Liabilities	3.58	3.53	4.58	7.99	1.12	1.51	1.27	1.08	0.88	0.26
Long-Term Debt	0	0	0	0	0.21	0	0	0	0	0
Other Long-Term Liabilities	2.92	3.52	4.12	0	0.67	0.56	2.29	0.6	0	0
Total Long-Term Liabilities	2.92	3.52	4.12	0	0.88	0.56	2.29	0.6	0	0
Total Liabilities	6.51	7.05	8.7	7.99	2	2.07	3.56	1.67	0.88	0.26
Total Debt	0	0	0	1.21	0.33	0	0	0	0	0
Debt Growth	-	-	-	266.37%	-	-	-	-	-	-
Retained Earnings	-46.2	-37.52	-28.07	-6.61	-31.13	-25.94	-19.74	-11.02	-6.3	-3.16
Shareholders' Equity	5.66	7.41	0.66	-6.61	4.58	4.3	5.82	8.79	3.24	4
Net Cash / Debt	10.69	12.85	7.48	-0.89	5.26	5.5	8.56	9.55	3.62	4.13
Net Cash / Debt Growth	-16.79%	71.77%	-	-	-4.36%	-35.78%	-10.35%	163.46%	-12.24%	-
Net Cash Per Share	-	-	0.28	-0.04	0.26	2548.25	4587.09	6285.77	2920.27	3757.32
Working Capital	7.7	9.84	3.62	-7.52	4.61	4.24	7.55	8.92	2.87	3.92
Book Value Per Share	5.74	18.34	0.03	-0.33	0.23	1992.12	3117.91	5788.90	2611.10	3637.78

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).